Table of contents
TCT Preview Summary 2
CS Spotlight on SPIRIT III 3-Year 4
CS Spotlight on SPIRIT IV 5
CS Spotlight on COMPARE 6
CS Spotlight on Transcatheter Valves 7
TCT Program Highlights 8
Monday September 21st 8
The Valvular Heart Disease Summit 8
The Drug-Eluting Stent Summit Part 1 10
Symposium: Transcatheter Valve Therapies 10
Tuesday, September 22nd 11
The Drug-Eluting Stent Summit Part 2 11
Edwards Lifesciences Analyst Reception 12
Symposium: Percutaneous Aortic Valve Therapies 12
Wednesday, September 23rd 13
Symposium: The Fourth Revolution: Fully Bioabsorbable Devices 13
Symposium: The Evolution of the Transcatheter Valve Experience 13
Plenary Session IX: The “Hottest” Topic of 2009: Transcatheter Aortic Valve Therapy 14
Late Breaking Clinical Trials 14
Abbott Laboratories Analyst Meeting 14
Symposium: The SPIRIT of Leadership 14
Thursday, September 24th 15
FDA Town Hall 15
Late Breaking Clinical Trials 16
Friday, September 25th 17
Late Breaking Clinical Trials 18
Appendix 19
Transcatheter Valve Clinical Data 20
Edwards’ SAPIEN Transcatheter Aortic Valve 20
Medtronic/CoreValve’s Transcatheter Aortic Valves 23
Heart Valves Overview 26
Transcatheter Valves 27
Edwards’ PARTNER Trial 28
Edwards’ PARTNER Trial Timeline 29
Coronary Stents Overview 30
Drug Eluting Stents 31
Drug Eluting Stent Clinical Trials 32
Glossary of Terms 37
Note: The stent image on the left on the front cover is from the FDA.gov website. The
photos of the transcatheter valves on the right front cover are courtesy of Edwards
Lifesciences.